- Author:
Seungsoo RHO
1
;
Sung Yong KANG
;
Samin HONG
;
Gong Je SEONG
;
Jong Jin JUNG
;
Chan Yun KIM
Author Information
- Publication Type:Original Article ; Comparative Study ; Research Support, Non-U.S. Gov't
- Keywords: Deep sclerectomy; Koreans; Open-angle glaucoma; Small collagen implant
- MeSH: Adult; Anterior Chamber/*surgery; Collagen/*administration & dosage; Drug Implants/*administration & dosage; Female; Follow-Up Studies; Glaucoma, Open-Angle/physiopathology/*surgery; Humans; Incidence; Intraocular Pressure; Male; Postoperative Complications/epidemiology; Postoperative Period; Republic of Korea/epidemiology; Retrospective Studies; Sclera/*surgery; Sclerostomy/*methods; Time Factors; Treatment Outcome; Visual Acuity
- From:Korean Journal of Ophthalmology 2013;27(1):34-38
- CountryRepublic of Korea
- Language:English
- Abstract: PURPOSE: To describe the long-term results of deep sclerectomy with collagen implant (DSCI) with or without adjuvant mitomycin C in Korean patients with primary or secondary open-angle glaucoma (OAG). METHODS: This retrospective review was comprised of 65 Korean patients who received DSCI with or without adjuvant mitomycin C due to primary or secondary OAG. Patients were followed for 72 months after surgery. Complete success was defined as intraocular pressure (IOP) <21 mmHg without medication and qualified success was defined as IOP <21 mmHg with or without medication. RESULTS: Mean postoperative follow-up period was 53.0 +/- 16.2 months. Mean IOP was 30.5 +/- 11.7 mmHg preoperatively, 8.4 +/- 4.3 mmHg at postoperative day one and 13.4 +/- 3.8 mmHg 60 months after surgery. The mean number of glaucoma medications was decreased from 3.6 +/- 1.1 to 1.6 +/- 1.3 at 60 months after the operation. Complete and qualified success rates were 36.7% and 79.6% at postoperative 60 months, respectively (Kaplan-Meier survival curve). No shallow or flat anterior chamber, endophthalmitis, or surgery-induced significant cataract was observed. CONCLUSIONS: The results of DSCI in Korean patients presented here seem reasonably excellent with qualified success rates of over 70% at six years with negligible complications.